Symbols

Symbols

SAGE

SAGE

SAGE Therapeutics Announces Nasdaq Delisting Following Merger and Board Changes

Supernus Completes Acquisition of Sage Therapeutics, Aiming for Growth and Diversification in Brain Health Medicines

Supernus completes acquisition of Sage Therapeutics, adds ZURZUVAE revenue.

Supernus Pharmaceuticals Acquires Sage Therapeutics to Strengthen Presence in Neuropsychiatric Conditions

Wednesday Jul 30, 2025

Sage Therapeutics Q2 revenue at $23.2mln, up 68% YoY.

Supernus Pharmaceuticals Shares Rise 3.1% After Upgrade and Acquisition News

Supernus Pharmaceuticals Completes Hart-Scott-Rodino Waiting Period for Sage Therapeutics Acquisition

Tuesday Jul 29, 2025

Supernus's 15min chart triggers Bollinger Bands Narrowing, KDJ Death Cross confirmed.

Sage Therapeutics Acquisition Advances Amid Antitrust Review Expiration and Analyst Forecasts

Supernus Pharmaceuticals Announces Expiration of HSR Waiting Period for Sage Therapeutics Acquisition

Monday Jul 28, 2025

Supernus 15-Min Chart Experiences Bollinger Bands Expanding Downward, Bearish Marubozu Pattern

Supernus Stock Sees Overbought RSI, Death Cross on 15-Minute Chart

Supernus Pharmaceuticals completes Hart-Scott-Rodino waiting period for Sage Therapeutics acquisition

Thursday Jul 10, 2025

Lipocine Hosts Virtual Event on LPCN 1154, Emphasizing Mental Health Treatment

Supernus' 15min chart triggers RSI overbought, KDJ death cross

Wednesday Jul 09, 2025

Indivior Appoints Vanessa Procter as EVP of Corporate Affairs, Enhancing Patient Access in OUD Treatment.

Tuesday Jul 08, 2025

Scotiabank Downgrades Sage Therapeutics to "Sector Perform", Adjusts Price Target to $9.20

Sage Therapeutics: Scotiabank Downgrades to Sector Perform, PT to $9.2 from $12

Monday Jul 07, 2025

Scotiabank Downgrades Sage Therapeutics to Sector Perform, Citing Acquisition by Supernus Pharmaceuticals.

Supernus Triggers MACD Death Cross, KDJ Death Cross on 15-Minute Chart.